NCT00997750View on ClinicalTrials.gov

Efficacy and Safety of Lornoxicam in Patients With Acute Coronary Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

June 30, 2009

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Lornoxicam

lornoxicam 8mg/day and 12mg/day for 15 days

Trial Locations (1)

Unknown

Central Clinical Hospital of Presidential Department Of Russian Federation, Moscow

All Listed Sponsors
lead

Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation

OTHER_GOV

NCT00997750 - Efficacy and Safety of Lornoxicam in Patients With Acute Coronary Syndrome | Biotech Hunter | Biotech Hunter